JS
James Scott Crowe
Current PSC Person with significant control at IMMUNOPHARMA CONSULTING LTD
Notified on 29th Nov 2024
James Scott Crowe
Reports & checks
Buy a company report
Run an identity check
Natures of control
- Ownership of shares 75 to 100 percent